These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19620698)

  • 21. Correlations between ankle circumference, symptoms, and quality of life demonstrate the clinical relevance of minimal leg swelling reduction: results of a study in 1,036 Argentinean patients.
    Guex JJ; Enrici E; Boussetta S; Avril L; Lis C; Taieb C
    Dermatol Surg; 2008 Dec; 34(12):1666-75. PubMed ID: 19018827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous leg ulcer in the context of chronic venous disease.
    Lozano Sánchez FS; Marinel lo Roura J; Carrasco Carrasco E; González-Porras JR; Escudero Rodríguez JR; Sánchez Nevarez I; Díaz Sánchez S; ; ;
    Phlebology; 2014 May; 29(4):220-6. PubMed ID: 23538963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of disease-specific quality of life tools in patients with chronic venous disease.
    Kuet ML; Lane TR; Anwar MA; Davies AH
    Phlebology; 2014 Dec; 29(10):648-53. PubMed ID: 23963729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
    Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
    Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
    Allegra C; Antignani PL
    Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in patients with chronic venous disease: influence of the socio-demographical and clinical factors.
    Lozano Sánchez FS; Sánchez Nevarez I; González-Porras JR; Marinello Roura J; Escudero Rodríguez JR; Díaz Sánchez S; Carrasco Carrasco E; ; ;
    Int Angiol; 2013 Aug; 32(4):433-41. PubMed ID: 23822947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic venous disease in Spain: doctor-patient correlation.
    Lozano Sánchez FS; Carrasco Carrasco E; Diaz Sánchez S; González Porras JR; Escudero Rodríguez JR; Marinello Roura J; Sánchez Nevarez I
    Eur J Vasc Endovasc Surg; 2012 Dec; 44(6):582-6. PubMed ID: 23073335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Perspectives and Management of Edema in Chronic Venous Disease-What about Ruscus?
    Bihari I; Guex JJ; Jawien A; Szolnoky G
    Medicines (Basel); 2022 Jul; 9(8):. PubMed ID: 35893088
    [No Abstract]   [Full Text] [Related]  

  • 29. Ruscus aculeatus (butcher's broom) as a potential treatment for orthostatic hypotension, with a case report.
    Redman DA
    J Altern Complement Med; 2000 Dec; 6(6):539-49. PubMed ID: 11152059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of microcirculatory parameters to evaluate clinical treatments of chronic venous disorder (CVD).
    Lascasas-Porto CL; Milhomens AL; Virgini-Magalhães CE; Fernandes FF; Sicuro FL; Bouskela E
    Microvasc Res; 2008 May; 76(1):66-72. PubMed ID: 18423497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of extract of Ruscus aculeatus in venous disease in the lower limbs.
    Cappelli R; Nicora M; Di Perri T
    Drugs Exp Clin Res; 1988; 14(4):277-83. PubMed ID: 3048951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study.
    Kahn SR; M'lan CE; Lamping DL; Kurz X; Bérard A; Abenhaim LA;
    J Vasc Surg; 2004 Apr; 39(4):823-8. PubMed ID: 15071450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and validation of a patient-reported outcome dedicated to chronic venous disorders: SQOR-V (specific quality of life and outcome response - venous).
    Guex JJ; Zimmet SE; Boussetta S; Nguyen C; Taieb C
    J Mal Vasc; 2007 Jul; 32(3):135-47. PubMed ID: 17616292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
    Boyle P; Diehm C; Robertson C
    Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age, body mass index and severity of primary chronic venous disease.
    Musil D; Kaletova M; Herman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):367-71. PubMed ID: 22336650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
    Beltramino R; Penenory A; Buceta AM
    Angiology; 2000 Jul; 51(7):535-44. PubMed ID: 10917578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linguistic validation of the 20 item-chronic venous disease quality-of-life questionnaire (CIVIQ-20).
    Launois R; Mansilha A; Lozano F
    Phlebology; 2014 Aug; 29(7):484-7. PubMed ID: 23563648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of venous thromboembolism on quality of life and severity of chronic venous disease.
    Kahn SR; M'Lan CE; Lamping DL; Kurz X; Bérard A; Abenhaim L;
    J Thromb Haemost; 2004 Dec; 2(12):2146-51. PubMed ID: 15613019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial.
    Carpentier P; van Bellen B; Karetova D; Hanafiah H; Enriquez-Vega E; Kirienko A; Dzupina A; Sabovic M; Reina Gutierrez L; Subwongcharoen S; Tüzün H; Maggioli A
    Int Angiol; 2017 Oct; 36(5):402-409. PubMed ID: 28206732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.